Author

Stefan Schreiber

Christian-Albrechts-Universität zu Kiel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Immunology· 3 Evolutionary Biology· 1 Genetics· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 5 Approach:statistical model· 5 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Assay:metabolomics· 2 Approach:benchmark study· 1 Assay:bulk RNA-seq· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

Bernd BokemeyeriD· 2 shared Bryan Howie· 2 shared Damon MayiD· 2 shared Hesham ElAbdiD· 2 shared Konrad AdeniD· 2 shared Mitchell W. PeseskyiD· 2 shared Philip C RosenstieliD· 2 shared A. Samer KadibalbaniD· 1 shared

Activity by Year

2016-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Bernd BokemeyerORCID

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Multi-centered T cell repertoire profiling identifies novel alterations in the immune repertoire of individuals with inflammatory bowel disease and validates previous findings

Aya K.H. Mahdy, Hesham ElAbd, Érika Endo Kokubun, Valeriia Kriukova, Mitchell W. Pesesky, Damon May, Christine Olbjørn, Gøri Perminow, May‐Bente Bengtson, Petr Ricanek, Svend Andersen, Trond Espen Detlie, Vendel Ailin Kristensen, Bjørn Allan Moum, M H Vatn, , IBSEN-III study group

The paper profiles T cell receptor alpha repertoires in IBD patients across multiple cohorts, identifies disease-associated clonotypes, and validates findings in an independent dataset.

Genome Medicine · Jan 9, 2026Peer-reviewedImmunology

Systematic screening of tryptophan metabolism identifies site- and microbial-specific signatures of tryptophan utilization in experimental colitis

Lina Welz, Abrar I Alsaadi, Danielle MM Harris, Meiping Yu, Taous Mekdoud, Johanna Bornhäuser, Eva Springer, Clara Gilloteau, Anant A. Pothakamury, Jaclyn D. Smith, Brenita C. Jenkins, Felix Sommer, Silvio Waschina, Philip Rosenstiel, Stefan Schreiber, , Konrad Aden

This study identifies microbial-specific Trp metabolism signatures in colitis by analyzing metabolites across multiple compartments in mice treated with DSS and antibiotics.

bioRxiv · Dec 18, 2025 · PreprintImmunology

Metabolic modeling reveals a multi-level deregulation of host-microbiome metabolic networks in IBD

Jan Taubenheim, A. Samer Kadibalban, Johannes Zimmermann, Claudia Taubenheim, Florian Tran, Stefan Schreiber, Philip C Rosenstiel, Konrad Aden, Christoph Kaleta

This study uses metabolic modeling to uncover host-microbiome metabolic dysregulation in IBD, identifying key pathways and potential therapeutic interventions.

Nature Communications · Jun 2, 2025Peer-reviewedSystems Biology

Neolithic introgression of IL23R-related protection against chronic inflammatory bowel diseases in modern Europeans

Ben Krause‐Kyora, Nicolas Antonio da Silva, Elif Kaplan, Daniel Kolbe, Sabine Schade-Lindig, Joachim Wahl, Carola Berszin, Michael Francken, Irina Görner, Kerstin Schierhold, Joachim Pechtl, Gisela Grupe, Johannes Müller, Inken Wohlers, Hauke Busch, , Stefan Schreiber

The paper traces the origin and spread of the IL23R variant rs11209026-A in Europe, linking its frequency changes to Neolithic agricultural practices and its protective role against inflammatory bowel diseases.

EBioMedicine · Feb 8, 2025Peer-reviewedEvolutionary Biology

Antigen-driven expansion of public clonal T cell populations in inflammatory bowel diseases

Mitchell Pesesky, Ramit Bharanikumar, Lionel Le Bourhis, Hesham ElAbd, Elisa Rosati, Cara L Carty, Namita Singh, Bernd Bokemeyer, Stefan Schreiber, Siegfried Görg, Marco Garcia Noceda, Paidamoyo Chapfuwa, Rachel M Gittelman, Damon May, Jennifer N Dines, , Matthieu Allez

The paper identifies public TCRB sequences expanded in CD or UC, associated with HLA alleles and antigen-specific immune responses, showing differential expansion in CD compared to UC and healthy controls.

bioRxiv · May 15, 2024Immunology

Insights into the genetic epidemiology of Crohn’s and rare diseases in the Ashkenazi Jewish population

Manuel A. Rivas, Jukka Koskela, Hailiang Huang, Christine Stevens, Brandon E. Avila, Talin Haritunians, Benjamin M. Neale, Mitja Kurki, Andrea Ganna, Daniel Graham, Benjamin Glaser, Inga Peter, Gil Atzmon, Nir Barzilai, Adam P. Levine, , Mark J. Daly

The paper analyzes exome sequencing data from Ashkenazi Jews to identify enriched alleles and their association with genetic risk for Crohn’s disease and rare diseases.

bioRxiv · Sep 25, 2016 · PreprintGenetics